Related references
Note: Only part of the references are listed.Evaluation of protective effects of GnRH agonist or antagonist on ovarian reserve with anti-M?llerian hormone and histological analysis in a rat model using cisplatin
Mustafa Tas et al.
ARCHIVES OF MEDICAL SCIENCE (2023)
Is Anti-Mullerian Hormone a Marker of Ovarian Reserve in Young Breast Cancer Patients Receiving a GnRH Analog during Chemotherapy?
Rosalba Torrisi et al.
BREAST CARE (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation
Gilad Karavani et al.
BMC WOMENS HEALTH (2021)
Anti-Mullerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals
Eduardo Hariton et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Perspectives on the development and future of oocyte IVM in clinical practice
Michel De Vos et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2021)
The Clinical Value and Interpretation of Anti-Mullerian Hormone in Women With Cancer
Richard A. Anderson et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Cryostorage and retransplantation of ovarian tissue as an infertility treatment
Christiani A. Amorim et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230
Halle C. F. Moore et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists
Marie-Madeleine Dolmans et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Ovarian function after ovarian transposition and additional pelvic radiotherapy: A systematic review
Ellen J. Hoekman et al.
EJSO (2019)
Gonadal Function Recovery and Fertility in Women Treated with Chemo- and/or Radiotherapy for Hodgkin's and Non-Hodgkin Lymphoma
Guido Gini et al.
CHEMOTHERAPY (2019)
Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
Maira Huerta-Reyes et al.
FRONTIERS IN ONCOLOGY (2019)
Gonadotropin Releasing Hormone Agonists Have an Anti-apoptotic Effect on Cumulus Cells
Paola Scaruffi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Fertility preservation in gynecologic cancers
Enes Taylan et al.
GYNECOLOGIC ONCOLOGY (2019)
Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy
Zeev Blumenfeld
CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH (2019)
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion
Alan Penzias et al.
FERTILITY AND STERILITY (2019)
GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer
Ying Zhong et al.
JOURNAL OF CANCER (2019)
Fertility preservation in female cancer patients: current knowledge and future perspectives
Sebastian Findeklee et al.
MINERVA GINECOLOGICA (2019)
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data
Matteo Lambertini et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
Kutluk Oktay et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Triptorelin for Fertility Preservation in Adolescents Treated With Chemotherapy for Cancer
Mariaclaudia Meli et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2018)
Fertility Sparing Treatment in Patients With Early Stage Endometrial Cancer, Using a Combination of Surgery and GnRH Agonist: A Monocentric Retrospective Study and Review of the Literature
Stephanie Tock et al.
FRONTIERS IN MEDICINE (2018)
A Combination of a GnRH Antagonist and Agonist for Fertility Preservation in an Adolescent Female Murine Model
Jennifer Flora Knudtson et al.
REPRODUCTIVE SCIENCES (2017)
Judging the Fertility protective Effect of GnRH Agonists in Chemotherapy - it is a Matter of perspective
Michael von Wolff et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Expression and Role of Gonadotropin-Releasing Hormone 2 and Its Receptor in Mammals
Amy T. Desaulniers et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Current Issues in Adolescent and Young Adult Cancer Survivorship
Hatem Soliman et al.
Cancer Control (2017)
Cancer and fertility preservation: international recommendations from an expert meeting
Matteo Lambertini et al.
BMC MEDICINE (2016)
Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning
R. Phelan et al.
BONE MARROW TRANSPLANTATION (2016)
Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity
M. F. Garrido-Oyarzun et al.
CLIMACTERIC (2016)
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial
Isabelle Demeestere et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Long term cause specific mortality among 34489 five year survivors of childhood cancer in Great Britain: population based cohort study
Miranda M. Fidler et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Long term cause specific mortality among 34489 five year survivors of childhood cancer in Great Britain: population based cohort study
Miranda M. Fidler et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer A Systematic Review and Meta-analysis
Rodrigo R. Munhoz et al.
JAMA ONCOLOGY (2016)
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies
M. Lambertini et al.
ANNALS OF ONCOLOGY (2015)
Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma
J. Meissner et al.
ANNALS OF ONCOLOGY (2015)
Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
A. S. Coates et al.
ANNALS OF ONCOLOGY (2015)
GnRH agonist for gonadal protection during chemotherapy
Tommaso Falcone et al.
HUMAN REPRODUCTION (2015)
GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro
Gamze Bildik et al.
HUMAN REPRODUCTION (2015)
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial
Matteo Lambertini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Fertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analogues
M. Huser et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2015)
Understanding Fertility in Young Female Cancer Patients
Kate E. Waimey et al.
JOURNAL OF WOMENS HEALTH (2015)
Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors
Zeev Blumenfeld et al.
ONCOLOGIST (2015)
LH-RH analogues in the treatment of young women with early breast cancer: Long-term follow-up of a phase II study
Francesco Recchia et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials
Lucia Del Mastro et al.
CANCER TREATMENT REVIEWS (2014)
Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications
Simone L. Broer et al.
HUMAN REPRODUCTION UPDATE (2014)
Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomes
M. Wong et al.
ANNALS OF ONCOLOGY (2013)
Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study
Xiaoyan Li et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2013)
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial
K. Behringer et al.
ANNALS OF ONCOLOGY (2012)
Chemotherapy and fertility
Zeev Blumenfeld
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2012)
Gonadotropin-releasing hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation
Zeev Blumenfeld et al.
FERTILITY AND STERILITY (2012)
What lies behind chemotherapy-induced ovarian toxicity?
Irit Ben-Aharon et al.
REPRODUCTION (2012)
Fertility preservation in women-a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT
Michael von Wolff et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2011)
Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer A Randomized Trial
Lucia Del Mastro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women
Hengxi Chen et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group
K. Behringer et al.
ANNALS OF ONCOLOGY (2010)
Repeated Spontaneous Pregnancies and Successful Deliveries After Repeated Autologous Stem Cell Transplantation and GnRH-Agonist Treatment
Zeev Blumenfeld et al.
ONCOLOGIST (2010)
Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide
Claudia N. C. D. Lemos et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2010)
Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with hodgkin lymphoma
Zeev Blumenfeld et al.
FERTILITY AND STERILITY (2008)
Gonadotropin-releasing hormone in the ovary
Chryssa Metallinou et al.
REPRODUCTIVE SCIENCES (2007)
Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy
Mitra Modares Gilan et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2007)
Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD)
Giuseppe Loverro et al.
HEMATOLOGY (2007)
GnRH agonists vs antagonists
B. C. Tarlatzis et al.
BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY (2007)
Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5
Y Kitajima et al.
ENDOCRINOLOGY (2006)
Ovarian stromal blood flow in the prediction of ovarian response during in vitro fertilization treatment
EHY Ng et al.
HUMAN REPRODUCTION (2005)
Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia
LE Bath et al.
HUMAN REPRODUCTION (2001)
Share Paper
